BioSpace News Archive

Growing demand for younger skin and minimal invasion procedures has fuelled the need for integrated fat transfer procedures.

Botulism (or botulism poisoning) is an uncommon, yet intense disease that transmits through food, contact with tainted soil, or through an open injury. Without early treatment, botulism can lead to paralysis, breathing challenges, and death.

Emergency medical supplies are an integral part of a health care system. These comprise specialized equipment and products to aid in the provision of emergency care.

The demand for point-of-care testing has increased significantly over the years. The growing demand for point-of-care testing and the escalating focus on accuracy, rapid testing measures, and data precision will serve as vital growth contributors for the microfluidics market through the forecast period of 2020-2030.

Intravenous fluid bags are an ideal means for the transportation of nutrients and other nutritious compounds for patients who cannot ingest anything through the oral route.

A thermodilution catheter is used to monitor right atrial pressure, right ventricular pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, and for continuous infusion of solutions.

Core One Labs Inc., is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. has commenced the development of its next-generation patent pending psychedelic drug formulation for the treatment of Alzheimer’s Disease.

The healthcare industry is undergoing a major overhaul in terms of technology. From the entry of robots, advancements in diagnostic care, patient monitoring, and drug development, the healthcare sector is embracing new technologies and evolving at a considerable pace.

Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations.

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations event.